Tissue angiotensin generation and regulation of vascular tone

Pharmacology & Therapeutics
J R CockcroftD J Webb


The renin-angiotensin system is intimately involved in the control of sodium and water balance, the activity of the sympathetic nervous system, mitogenesis and the regulation of vascular tone. There is evidence that many of these effects may be controlled at a local level by independent tissue renin-angiotensin systems. Drugs that are specific inhibitors of the cascade have proved powerful tools for dissecting the physiology of the renin-angiotensin system, and are of major benefit in the treatment of hypertension and chronic heart failure. Recent evidence suggests that variations in the genes coding for components of the system may affect the risk of developing hypertension and ischaemic heart disease.


Mar 12, 1976·Science·P R CaldwellR L Soffer
Oct 1, 1977·Physiological Reviews·T C Westfall
Jan 1, 1979·Neuroscience·D J Ramsay
Mar 27, 1975·The New England Journal of Medicine·D H StreetenT G Dalakos
Apr 1, 1979·Clinical Science·J D Swales
Nov 1, 1978·British Journal of Clinical Pharmacology·B F Robinson
May 1, 1977·The Journal of Clinical Endocrinology and Metabolism·P F Semple
Apr 1, 1992·British Journal of Pharmacology·W Linz, B A Schölkens
Oct 15, 1992·Nature·T W Kurtz
Oct 1, 1992·The American Journal of Physiology·S J King, S Oparil
Oct 2, 1992·Cell·X JeunemaitreJ M Lalouel
Dec 1, 1991·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·L A SechiM Schambelan
Jul 1, 1991·Hypertension·W FischliQ Branca
Apr 11, 1991·American Journal of Hypertension·P C WongP B Timmermans
Sep 1, 1991·The Journal of Clinical Investigation·E F GradyJ E Kalinyak
Aug 1, 1991·Trends in Pharmacological Sciences·K Catt, A Abbott
Apr 1, 1990·The Journal of Clinical Investigation·T W KurtzB L Hjelle
Mar 1, 1991·Hypertension·K R Lynch, M J Peach
Apr 1, 1991·The Journal of Clinical Investigation·A J NaftilanV J Dzau
Feb 1, 1991·Trends in Pharmacological Sciences·P B TimmermansW F Herblin

❮ Previous
Next ❯


Mar 21, 1998·The Journal of Clinical Investigation·G A RongenJ S Floras
Jul 1, 2008·Pharmacology & Therapeutics·Daphne MerkusDirk J Duncker
Dec 18, 2003·The American Journal of Medicine·Paresh DandonaAjay Chaudhuri
Aug 17, 2004·The Medical Clinics of North America·Paresh DandonaAhmad Aljada
Sep 10, 2002·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A M SugawaraL A De Luca
Sep 24, 2010·Journal of Cardiovascular Pharmacology and Therapeutics·Hong Xia WangLi Ke Zhang
Nov 14, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Justin L GrobeMichael J Katovich
Mar 19, 2019·British Journal of Pharmacology·Gema Mondéjar-ParreñoAngel Cogolludo
Jan 1, 1997·Journal of Basic and Clinical Physiology and Pharmacology·B Adegunloye, O Sofola

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.